Back فينوكسي بنزامين Arabic فنوکسی بنزامین AZB Ffenocsybensamin Welsh Phenoxybenzamin German Fenoxibenzamina Spanish فنوکسی بنزامین Persian Fenossibenzamina Italian フェノキシベンザミン Japanese ଫେନୋକ୍ସିବେଞ୍ଜାମିନ OR Fenoksybenzamina Polish

Phenoxybenzamine

Phenoxybenzamine
Clinical data
Trade namesDibenzyline
AHFS/Drugs.comMonograph
MedlinePlusa682059
Pregnancy
category
  • AU: B2
Routes of
administration		Oral
ATC code
Pharmacokinetic data
Elimination half-life24 hours
Identifiers
  • (RS)-N-Benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.406 Edit this at Wikidata
Chemical and physical data
FormulaC18H22ClNO
Molar mass303.83 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • ClCCN(C(COc1ccccc1)C)Cc2ccccc2
  • InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3 checkY
  • Key:QZVCTJOXCFMACW-UHFFFAOYSA-N checkY
  (verify)

Phenoxybenzamine (PBZ,[1] marketed under the trade names Dibenzyline and Dibenyline) is a non-selective, irreversible alpha blocker.

  1. ^ Bradley K. "Clinical Guideline: Phaeochromocytoma Diagnosis and Management" (PDF). University Hospitals Bristol. NHS Foundation Trust. Archived from the original (PDF) on 25 March 2023.

Rich TVX News Network Site

Rich TVX News Network Info

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search